Folbigg's DNA variant 'exceptionally rare'

November 14, 2022 12:31 PM AEDT | By AAPNEWS
Image source: AAPNEWS

A cardiologist has told the second inquiry into Kathleen Folbigg's convictions for killing four of her children a genetic variant identified in herself and her two daughters is exceptionally rare.

The inquiry, being conducted by former chief justice Tom Bathurst, began in Sydney on Monday.

The retired judge was appointed in May after the NSW Governor received a petition from prominent scientists asking Folbigg be pardoned due to new scientific evidence.

Her lawyers have submitted the evidence indicates a genetic mutation could be responsible for the deaths of two of the children.

Known as CALM2 G114R, the variant affects the calmodulin protein and the body's ability to bind calcium.

It has been identified in Folbigg and her daughters Sarah and Laura, and can affect the electrical activity of the heart, Monday's hearing was told.

However, very little is known about the variant, cardiac electrophysiologist Hariharan Raju told the hearing.

"Calmodulin variants are relatively recently described and are exceptionally rare conditions," Associate Professor Raju said.

"So much so, as someone with an interest in cardiogenetic disease … (she) is the first individual that I have personally been involved with."

He conducted an electrocardiograph on Folbigg before the earlier inquiry, but aside from viewing historical results of other tests, has not consulted with her since 2019.

"To my knowledge no other cardiologist has consulted with her," Prof Raju said.

He said he had been asked by a legal team to run a specific test, "which is not the normal patient-physician relationship".

Folbigg has declined to participate in further tests ahead of the current inquiry.

"Overall, I still feel she doesn't have sufficient data to confirm a diagnosis," Prof Raju said, noting she did have some minor abnormalities.

"When I consulted with her, although the DNA variant had been identified, it wasn't clear at that point whether it was responsible for any disease at all," he said.

"I essentially kept an open mind in the context of her family history as to what might be the underlying condition that ties together all the tragic events in her family."

Counsel assisting the inquiry, Sophie Callan SC, asked what tragic events he referred to.

"The deaths of her four children," he said.

Folbigg was jailed in 2003 after being convicted of murdering her children Patrick, Laura and Sarah, and the manslaughter of her son Caleb.

Former NSW District Court chief judge Reg Blanch conducted the 2019 inquiry, concluding her guilt was "even more certain".

Folbigg previously lost challenges in the NSW Court of Criminal Appeal, the High Court and the NSW Court of Appeal.

Ms Callan has acknowledged the "unusual position" of the inquiry being held soon after the earlier inquiry based on asserted new scientific evidence.

She began on Monday summarising the deaths of the children, the subsequent trial, and the 2019 inquiry, noting the science of genetics has evolved over the years.

"There was a huge amount of progress between the trial in 2003 and the inquiry in 2019, with more progress since then," Ms Callan said.

Mr Bathurst's task is to form his own view about whether there is reasonable doubt about Folbigg's guilt.

She was initially sentenced to 40 years' imprisonment, with a non-parole period of 30 years, but an appeal later reduced her sentence to 30 years with a non-parole period of 25 years.

She's not eligible for parole until 2028.

Scientists calling for her early release argue there is no medical evidence she smothered the children she has been convicted of killing.

The hearing continues.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.